Odaia
ODAIA provides an AI-driven commercial analytics platform for pharmaceutical companies, using predictive modeling and customer journey data to help sales, marketing, and access teams prioritize healthcare providers and optimize omnichannel engagement. The company sells its software on a subscription basis to life sciences organizations seeking to improve field force productivity and brand performance.
- Revenue
- <$10M
- Employees
- 51 - 200
- Founded
- 2018
- Headquarters
- Toronto, Canada
Odaia customers on Arbolus
Customers who reviewed Odaia
Seniority of Odaia customers
Most people who reviewed Odaia hold Director roles (86%), followed by C-Suite (14%).
- Director 86%
- C-Suite 14%
Customers sample
Employer names and spend open once the report publishes.
What 7 Arbolus experts think of Odaia
NPS scores among ODAIA customers range from 5 to 9, with 67% of users reporting an NPS of 7 or above. Renewal intent is not disclosed, but stickiness is high: 67% of customers have used ODAIA for over a year, suggesting entrenched value. Users in pilot or early stages still provide moderate-to-high NPS scores. Sentiment is thus moderately positive, primarily concentrated within enterprise pharma user groups. Positive
Tell us when the Odaia report publishes.
We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.
Sentiment
14 Net Promoter Score, from 7 scored reviews- Promoters 2
- Passives 4
- Detractors 1
Written answers and themes publish with the full report.
Renewal intent
Plan to renew 100%Plan to renew, by seniority
- 100% 1 answer
- 8/10 Average score from customers who will renew
For people who use Odaia
Do you use Odaia at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 7 customers of Odaia have already contributed
Takes a few minutes. Your identity stays anonymous.